Laparoscopic Radical Resection Combined with Neoadjuvant Chemotherapy in Treatment of Colorectal Cancer: Clinical Efficacy and Postoperative Complications

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2022 Jan 17

PMID 35035739

Authors

Shengchao Wei

Jie Xi

Shuai Cao

Tao Li

Jiacheng Xu

Wei Li

Yuhe Bi

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the clinical efficacy of laparoscopic radical resection combined with neoadjuvant chemotherapy (NACT) in the treatment of colorectal cancer and its influence on postoperative complications.

Methods: The clinical data of 90 patients with colorectal cancer admitted to our hospital from June 2019 to June 2021 were retrospectively analyzed. According to different treatment methods, patients were divided into a control group (laparoscopic radical resection) and a study group (combined NACT before radical resection), with 45 cases in each group. The efficacy and complications were compared between the two groups after treatment.

Results: Postoperatively, the early oral feeding, anal exhaust time, and hospitalization time of the patients in the study group were significantly shorter than those in the control group (P<0.05). The study group had significantly lower cancer metastasis rate, recurrence rate, infection rate, and smaller tumor diameters than the control group (P<0.05). The levels of tumor markers (CEA, CA242, CA199, and CA724) were reduced significantly in both groups after treatment, with lower results observed in the study group (P<0.05). The average survival time of patients in the study group was significantly longer than that of the control group (16.04±3.64 vs 11.88±2.53 months; t=6.295, P<0.001). The two groups showed no significant differences in the incidence of complications (P>0.05).

Conclusion: Laparoscopic radical resection of colorectal cancer combined with NACT is a preferred technique for the treatment of colorectal cancer. It effectively facilitates the postoperative recovery, reduces the levels of tumor markers, boosts the short-term curative effect, and prolongs the average survival time, without obvious complications.

Citing Articles

Predictive value of physiological capacity and surgical stress scores for perioperative complications in radical resection for colorectal cancer: a propensity-matched analysis.

Li Y, Wang B, Tsang L, Zou M, Yu L, Xia S Am J Transl Res. 2025; 17(1):254-266.

PMID: 39959239 PMC: 11826193. DOI: 10.62347/JZKO9876.

Prediction model construction for the occurrence of LARS after neoadjuvant therapy combined with laparoscopic total mesorectal excision in male patients with mid-low rectal cancer.

Wang D, Peng X, Yu M Front Oncol. 2024; 14:1492245.

PMID: 39735602 PMC: 11671363. DOI: 10.3389/fonc.2024.1492245.

Artificial intelligent patient-controlled intravenous analgesia improves the outcomes of older patients with laparoscopic radical resection for colorectal cancer.

Liu D, Li X, Nie X, Hu Q, Wang J, Hai L Eur Geriatr Med. 2023; 14(6):1403-1410.

PMID: 37847474 PMC: 10754746. DOI: 10.1007/s41999-023-00873-z.

Efficacy of Laparoscopic Radical Resection Combined with Neoadjuvant Chemotherapy and Its Impact on Long-Term Prognosis of Patients with Colorectal Cancer.

Huang L, Xu X, Shao J, Hong W, Yu W Evid Based Complement Alternat Med. 2022; 2022:4774531.

PMID: 35983001 PMC: 9381182. DOI: 10.1155/2022/4774531.

References

Qi Y, Yao X, Zhang B, Du X . Comparison of recovery effect for sufentanil and remifentanil anesthesia with TCI in laparoscopic radical resection during colorectal cancer. Oncol Lett. 2016; 11(5):3361-3365. PMC: 4841051. DOI: 10.3892/ol.2016.4394. View

Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T . Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy. Br J Cancer. 2018; 119(4):419-423. PMC: 6134007. DOI: 10.1038/s41416-018-0208-5. View

Hirokawa F, Asakuma M, Komeda K, Shimizu T, Inoue Y, Kagota S . Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?. Surg Today. 2018; 49(1):82-89. DOI: 10.1007/s00595-018-1716-x. View

Li Q, Du L, Lu L, Tong Y, Wu S, Yang Y . Clinical Application of Enhanced Recovery After Surgery in Perioperative Period of Laparoscopic Colorectal Cancer Surgery. J Laparoendosc Adv Surg Tech A. 2019; 29(2):178-183. DOI: 10.1089/lap.2018.0708. View

Yang L, Ma W, Wang M, Zhang R, Bi T, Zhou S . Efficacy of intestinal obstruction stent combined with laparoscopic surgery and neoadjuvant chemotherapy in patients with obstructive colorectal cancer. Oncol Lett. 2019; 18(2):1931-1937. PMC: 6614675. DOI: 10.3892/ol.2019.10525. View

Leimkuhler M, Hemmer P, Reyners A, de Groot D, van Ginkel R, Been L . Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study. World J Surg Oncol. 2019; 17(1):14. PMC: 6330449. DOI: 10.1186/s12957-018-1554-8. View

Baretti M, Rimassa L, Personeni N, Giordano L, Tronconi M, Pressiani T . Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study. Clin Colorectal Cancer. 2018; 17(3):e489-e498. DOI: 10.1016/j.clcc.2018.03.010. View

Yoshimoto Y, Fujikawa T, Tanaka A, Hayashi H, Shimoike N, Kawamoto H . Optimal use of antiplatelet agents, especially aspirin, in the perioperative management of colorectal cancer patients undergoing laparoscopic colorectal resection. World J Surg Oncol. 2019; 17(1):92. PMC: 6545215. DOI: 10.1186/s12957-019-1634-4. View

Kwak H, Ju J, Lee S, Kim C, Kim Y, Kim H . Comparison of Right-side and Left-side Colon Cancers Following Laparoscopic Radical Lymphadenectomy. J Invest Surg. 2019; 34(2):142-147. DOI: 10.1080/08941939.2019.1608334. View

10.

Sun Y, Zhang Z, Zhou Y, Li P, Zeng Q, Zhang X . High ligation of the inferior mesenteric artery with nerve-sparing in laparoscopic surgery for advanced colorectal cancer. Tech Coloproctol. 2020; 25(3):343-344. DOI: 10.1007/s10151-020-02355-x. View

11.

Yang X, Li G, Luo G, Zhong S, Ding Z . New insights into autonomic nerve preservation in high ligation of the inferior mesenteric artery in laparoscopic surgery for colorectal cancer. Asian Pac J Cancer Prev. 2014; 15(6):2533-9. DOI: 10.7314/apjcp.2014.15.6.2533. View

12.

Crolla R, Tersteeg J, van der Schelling G, Wijsman J, Schreinemakers J . Robot-assisted laparoscopic resection of clinical T4b tumours of distal sigmoid and rectum: initial results. Surg Endosc. 2018; 32(11):4571-4578. DOI: 10.1007/s00464-018-6210-4. View

13.

Kwakman R, Schrama A, van Olmen J, Otten R, de Lange-de Klerk E, de Cuba E . Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases: A Meta-analysis. Ann Surg. 2016; 263(6):1102-11. DOI: 10.1097/SLA.0000000000001593. View

14.

Bhangu J, Beer A, Mittlbock M, Tamandl D, Pulverer W, Schonthaler S . Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis. Ann Surg. 2018; 268(5):894-902. DOI: 10.1097/SLA.0000000000002901. View

15.

Tajima T, Mukai M, Yokoyama D, Higami S, Uda S, Hasegawa S . Comparison of hand-assisted laparoscopic surgery (HALS) and conventional laparotomy in patients with colorectal cancer: Final results from a single center. Oncol Lett. 2017; 13(6):4953-4958. PMC: 5452917. DOI: 10.3892/ol.2017.6035. View

16.

Simoneau E, Alanazi R, Alshenaifi J, Molla N, Aljiffry M, Medkhali A . Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases. J Surg Oncol. 2016; 113(4):449-55. DOI: 10.1002/jso.24139. View

17.

Zhou M, Gu X, Xiang J, Chen Z . Clinical safety and outcomes of laparoscopic surgery versus open surgery for palliative resection of primary tumors in patients with stage IV colorectal cancer: a meta-analysis. Surg Endosc. 2015; 30(5):1902-10. DOI: 10.1007/s00464-015-4409-1. View

18.

Chen H, Lin J, Chen J, Chuang C, Liu M, Wang J . Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial. Asia Pac J Clin Oncol. 2017; 14(1):61-68. DOI: 10.1111/ajco.12692. View

19.

Kitagawa Y, Kitano S, Kubota T, Kumai K, Otani Y, Saikawa Y . Minimally invasive surgery for gastric cancer--toward a confluence of two major streams: a review. Gastric Cancer. 2005; 8(2):103-10. DOI: 10.1007/s10120-005-0326-7. View

20.

Yang K, Zhang F, Han P, Wang Z, Deng K, Zhang Y . Metabolomics approach for predicting response to neoadjuvant chemotherapy for colorectal cancer. Metabolomics. 2019; 14(9):110. DOI: 10.1007/s11306-018-1406-0. View